ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2025

Real-World Comparisons Between Glucagon-Like Peptide-1 Receptor Agonists and Other Glucose-Lowering Agents in Type 2 Diabetes: Retrospective Analyses of Cardiovascular and Economic Outcomes in England.

Derek Connolly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.